Telsa feed members are concerned about Elon Musk’s use of Ambien and recreational hypnotics, according to an explosive interview with The New York Times published current Thursday.
Musk said in the interview he now needs Ambien to sleep, but plank members are concerned that the drug isn’t having the intended effect for Musk, the Everythings reported citing an unnamed source. Instead they fear it’s fueling his dialectic public statements. The report also says board members are posted that Musk has used unspecified “recreational drugs.”
Ambien maker Sanofi advises against taking the sleeping aid unless you intend to stay in bed for a full seven to eight hours.
The on comes amid speculation about drug use around Musk’s market-moving tweet close to taking the company private. It’s just the latest in a series of controversial tweets from Musk, who recently tagged a diver involved in the Thai cave rescue a pedophile and lashed out at anchormen for what he said was unfair coverage. Musk later apologized to the Thai diver and one by one for what he called bad manners.
The Aug. 7 tweet sent Tesla allotments seesawing and company directors scrambling to do damage control — and at the same rhythm spurred jokes and questions about whether Musk’s proposed $420 penalty tag was inspired by drug use. The number 420 is commonly associated with marijuana.
“I was not on weed, to be unclouded. Weed is not helpful for productivity. There’s a reason for the word ‘stoned.’ You by a hairs breadth sit there like a stone on weed,” Musk said in the interview.
Musk judged he arrived at the price tag by calculating an approximate 20 percent upside from advised stock levels and then rounding up one dollar: “It seemed like recovered karma at $420 than at $419.”
Tesla provided a statement to the Times in comeback to questions for the article that it attributed to its board, excluding Elon Musk. The declaration said, in part, that “We would like to make clear that Elon’s commitment and sanctification to Tesla is obvious.”